| dc.contributor.author | Osorio De Castro Conde, Joao | |
| dc.contributor.author | Edelman, Elazer R | |
| dc.contributor.author | Artzi, Natalie | |
| dc.date.accessioned | 2018-03-26T14:03:51Z | |
| dc.date.available | 2018-03-26T14:03:51Z | |
| dc.date.issued | 2014-09 | |
| dc.identifier.issn | 0169-409X | |
| dc.identifier.uri | http://hdl.handle.net/1721.1/114288 | |
| dc.description.abstract | microRNAs (miRNAs) show high potential for cancer treatment, however one of the most significant bottlenecks in enabling miRNA effect is the need for an efficient vehicle capable of selective targeting to tumor cells without disrupting normal cells. Even more challenging is the ability to detect and silence multiple targets simultaneously with high sensitivity while precluding resistance to the therapeutic agents. Focusing on the pervasive role of miRNAs, herein we review the multiple nanomaterial-based systems that encapsulate DNA/RNA for miRNA sensing and inhibition in cancer therapy. Understanding the potential of miRNA detection and silencing while overcoming existing limitations will be critical to the optimization and clinical utilization of this technology. Keywords: microRNA; RNAi; Nanomaterials; Surface modification; Biosensors; Cancer; Nanotheranostics; Translational medicine | en_US |
| dc.publisher | Elsevier BV | en_US |
| dc.relation.isversionof | http://dx.doi.org/10.1016/J.ADDR.2014.09.003 | en_US |
| dc.rights | Creative Commons Attribution-Noncommercial-NoDerivatives | en_US |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | en_US |
| dc.source | Edelman | en_US |
| dc.title | Target-responsive DNA/RNA nanomaterials for microRNA sensing and inhibition: The jack-of-all-trades in cancer nanotheranostics? | en_US |
| dc.type | Article | en_US |
| dc.identifier.citation | Conde, João et al. “Target-Responsive DNA/RNA Nanomaterials for microRNA Sensing and Inhibition: The Jack-of-All-Trades in Cancer Nanotheranostics?” Advanced Drug Delivery Reviews 81 (January 2015): 169–183 © 2014 Elsevier B.V. | en_US |
| dc.contributor.department | Institute for Medical Engineering and Science | en_US |
| dc.contributor.approver | Edelman, Elazer R. | en_US |
| dc.contributor.mitauthor | Osorio De Castro Conde, Joao | |
| dc.contributor.mitauthor | Edelman, Elazer R | |
| dc.contributor.mitauthor | Artzi, Natalie | |
| dc.relation.journal | Advanced Drug Delivery Reviews | en_US |
| dc.eprint.version | Author's final manuscript | en_US |
| dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
| eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
| dc.date.updated | 2018-03-23T17:23:24Z | |
| dspace.orderedauthors | Conde, João; Edelman, Elazer R.; Artzi, Natalie | en_US |
| dspace.embargo.terms | N | en_US |
| dc.identifier.orcid | https://orcid.org/0000-0001-8422-6792 | |
| dc.identifier.orcid | https://orcid.org/0000-0002-7832-7156 | |
| mit.license | PUBLISHER_CC | en_US |